Researchers demonstrate AI-enhanced MRI's potential in diagnosing endometrial cancer, achieving superior accuracy and ...

And the incidence of endometrial cancer is growing worldwide, likely due to multiple factors. “One is an aging population, as ...

Boston Children's Hospital and Harvard Medical School researchers have discovered a neuroimmune communication pathway that ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...

The addition of a progestin to estrogen in HRT in women with an intact uterus reduces the risk of endometrial hyperplasia and cancer but increases the risk of breast cancer. The increase in ...

There are roughly 7,700 new cases of endometrial cancer each year in the UK, of these around 170 women could be eligible for treatment with GSK's antibody, which has also been approved in the US ...

By Michelle Trauring Linda Rawdin is a self-proclaimed cancer detective. “You solve it like a crime,” she said during a ...

Ovarian cancer is a relatively manageable malignancy when diagnosed at an early stage, but late-stage detection almost always translates into a poor prognosis. Researchers have been vigorously ...

Dr. Shannon Westin (Host), Dr. Brian Slomovitz (Guest) Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article “Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without ...

A curated review of what has happened in endometrial cancer research in 2024, including expert commentary, FDA approvals, healthcare disparities, AI, immunotherapies, and more.